Results 21 to 30 of about 8,495 (251)

Medical therapy with flecainide and propafenone in atrial fibrillation: Long-term clinical experience in the tertiary care setting

Cardiology Journal, 2023
BACKGROUND: Flecainide and propafenone are Class Ic antiarrhythmic drugs that block the cardiac fast inwards Na+ current and are used for rhythm control in patients with atrial fibrillation (AF). However, data on long-term clinical efficacy and safety of
Boldizsar Kovacs, Haci Yakup Yakupoglu, Urs Eriksson, Nazmi Krasniqi, Firat Duru   +4 more
doaj   +1 more source

Botulinum Toxin-Chitosan Nanoparticles Prevent Arrhythmia in Experimental Rat Models

Marine Drugs, 2020
Several experimental studies have recently demonstrated that temporary autonomic block using botulinum toxin (BoNT/A1) might be a novel option for the treatment of atrial fibrillation.
David Sergeevichev, Vladislav Fomenko, Artem Strelnikov, Anna Dokuchaeva, Maria Vasilieva, Elena Chepeleva, Yanina Rusakova, Sergey Artemenko, Alexander Romanov, Nariman Salakhutdinov, Alexander Chernyavskiy   +10 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Fear of exercise and health-related quality of life in patients with an implantable cardioverter defibrillator [PDF]

, 2003
Several studies have reported improved survival rates thanks to the use of an implantable cardioverter defibrillator (ICD) in the treatment of patients with life-threatening arrhythmia.
Coster, Jenifer, Coster, J., van Ittersum, Miriam, van Gelder, I., Brugemann, J., de Greef, Mathieu, van der Schans, Cees, van Ittersum, M., van der Schans, C., de Greef, M., van Gelder, Isabelle, Brügemann, Johan   +11 more
core   +1 more source

Relationships Between Bronchodilators, Steroids, Antiarrhythmic Drugs, Antidepressants, and Benzodiazepines and Heart Disease and Ischemic Stroke in Patients With Predominant Bronchiectasis and Asthma

Frontiers in Cardiovascular Medicine, 2022
ObjectiveWe investigated the effects of medication on heart disease and ischemic stroke (HDS) risk in patients with predominant bronchiectasis-asthma combination (BCAS).MethodsBCAS and non-BCAS cohorts (N = 588 and 1,118, respectively) were ...
Jun-Jun Yeh, Jun-Jun Yeh, Mei-Chu Lai, Yu-Cih Yang, Yu-Cih Yang, Chung-Y. Hsu, Chia-Hung Kao, Chia-Hung Kao, Chia-Hung Kao, Chia-Hung Kao   +9 more
doaj   +1 more source

Differential Free Intracellular Calcium Release by Class II Antiarrhythmics in Cancer Cell Lines [PDF]

, 2019
Class II antiarrhythmics or β-blockers are anti-sympathetic nervous system agents and act by blocking β-adrenoceptors. Despite their common clinical use, little is known about the effects of β-blockers on free intracellular calcium (Ca2+i), an important ...
Ahmed, Aamir, Thrasivoulou, C, Dasgupta, P, Dasgupta, Prokar, Ashmore, JF, Ashmore, Jonathan F., Sørensen, NM, Ahmed, A, Reyes Corral, Marta; id_orcid, Reyes-Corral, M, Thrasivoulou, Christopher, Sørensen, Naja M.   +11 more
core   +2 more sources

Risk of Severe Hypoglycemia Associated With Concomitant Use of Sulfonylureas and Amiodarone. [PDF]

Diabetes Obes Metab
ABSTRACT Aims To evaluate whether initiation of amiodarone while receiving sulfonylurea is associated with an increased risk of severe hypoglycemia compared with the initiation of other antiarrhythmic agents (flecainide, sotalol, or propafenone) while receiving sulfonylurea. Materials and Methods We conducted a population‐based cohort study using South
Bea S, Lee H, Cho YM, Choi YJ, Shin JY, Bykov K.   +5 more
europepmc   +2 more sources

New Advancements in the Development of Antiarrhythmics

, 2021
Medicine is a constantly evolving field. As technology grows, so do the tools used in healthcare. Pharmaceutical medications are one of the tools that has seen great advancements over the years.
Patil, Prabhudev
core  

antiarrhythmic pharmacotherapy during SARS-COV-2 pandemic

, 2021
This thesis offers a review of antiarrhythmic drugs with an emphasis on antiarrhythmic therapy during SARS-CoV-2 pandemic. Includes the general mechanisms causing arrhythmias with and without SARS-CoV-2 infection.
Meltzer, Maya Di
core  

Amiodarone-related Pneumonitis

Journal of the Formosan Medical Association, 2007
Amiodarone-related pneumonitis is a potentially limiting factor for amiodarone usage. However, it is believed that amiodarone-related pneumonitis is unlikely to occur during low-dose and short courses of therapy. We report three patients who received low-
Sheng-Nan Chang, Juey-Jen Hwang, Kuan-Lih Hsu, Chia-Ti Tsai, Ling-Ping Lai, Jiunn-Lee Lin, Chuen-Den Tseng, Fu-Tien Chiang   +7 more
doaj   +1 more source